Literature DB >> 22837389

Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone.

Su-Young Choi1, Kwi Hye Koh, Hyunyoung Jeong.   

Abstract

Results from clinical studies suggest that pregnancy alters hepatic drug metabolism in a cytochrome P450 (P450) isoform-specific manner, and rising concentrations of female hormones are potentially responsible for the changes. The objective of this study was to comprehensively characterize the effects of estrogen and progesterone on the expression and activity of major drug-metabolizing P450s. To this end, primary human hepatocytes were treated with estradiol and progesterone, and mRNA expression and activity levels of 10 different P450 isoforms were determined. The results showed that estradiol enhances CYP2A6, CYP2B6, and CYP3A4 expression, whereas progesterone induces CYP2A6, CYP2B6, CYP2C8, CYP3A4, and CYP3A5 expression. The induction was mainly observed when the average hormone concentrations were at the levels reached during pregnancy, suggesting that these effects are likely pregnancy-specific. Estradiol also increased enzyme activities of CYP2C9 and CYP2E1 without affecting the mRNA expression levels by unknown mechanisms. Taken together, our results show differential effects of estrogen and progesterone on P450 expression, suggesting involvement of different regulatory mechanisms in female hormone-mediated P450 regulation. Our findings potentially provide a basis in mechanistic understanding for altered drug metabolism during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837389      PMCID: PMC3558868          DOI: 10.1124/dmd.112.046276

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  46 in total

1.  Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer.

Authors:  Reto Stricker; Raphael Eberhart; Marie-Christine Chevailler; Frank A Quinn; Paul Bischof; René Stricker
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

Review 2.  Nongenomic actions of steroid hormones in reproductive tissues.

Authors:  A Revelli; M Massobrio; J Tesarik
Journal:  Endocr Rev       Date:  1998-02       Impact factor: 19.871

3.  Hepatic microsomal metabolism of drugs during pregnancy in the rat.

Authors:  M E Dean; B H Stock
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

Review 4.  Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance.

Authors:  Rheem A Totah; Allan E Rettie
Journal:  Clin Pharmacol Ther       Date:  2005-05       Impact factor: 6.875

Review 5.  Pharmacokinetics of oestrogens and progestogens.

Authors:  H Kuhl
Journal:  Maturitas       Date:  1990-09       Impact factor: 4.342

6.  Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats.

Authors:  Su-Young Choi; Liam Fischer; Kyunghee Yang; Hyejin Chung; Hyunyoung Jeong
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

7.  Accelerated metabolism of nicotine and cotinine in pregnant smokers.

Authors:  Delia Dempsey; Peyton Jacob; Neal L Benowitz
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

8.  Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes.

Authors:  D J Waxman; G A Dannan; F P Guengerich
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

9.  Hormonal regulation of rat liver microsomal enzymes. Role of gonadal steroids in programming, maintenance, and suppression of delta 4-steroid 5 alpha-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450.

Authors:  G A Dannan; F P Guengerich; D J Waxman
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

10.  Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy.

Authors:  Huiqing Chen; Kyunghee Yang; Suyoung Choi; James H Fischer; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2009-06-22       Impact factor: 3.922

View more
  49 in total

1.  Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Jashvant D Unadkat
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

2.  Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.

Authors:  Ming-Fen Ho; Cristina Correia; James N Ingle; Rima Kaddurah-Daouk; Liewei Wang; Scott H Kaufmann; Richard M Weinshilboum
Journal:  Biochem Pharmacol       Date:  2018-04-03       Impact factor: 5.858

Review 3.  Transcriptional Regulation of CYP2D6 Expression.

Authors:  Xian Pan; Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2016-10-03       Impact factor: 3.922

4.  Transdermal Estradiol Treatment for Postpartum Depression: A Pilot, Randomized Trial.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Eydie L Moses-Kolko; Kara E Driscoll; Beth A Prairie; Catherine S Stika; Heather F Eng; John L Dills; James F Luther; Stephen R Wisniewski
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

5.  Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.

Authors:  Pyry A Välitalo; Heidi Kemppainen; Aida Kulo; Anne Smits; Kristel van Calsteren; Klaus T Olkkola; Jan de Hoon; Catherijne A J Knibbe; Karel Allegaert
Journal:  Br J Clin Pharmacol       Date:  2017-05-14       Impact factor: 4.335

6.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

7.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

8.  Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.

Authors:  Wenndy Hernandez; Keston Aquino-Michaels; Katarzyna Drozda; Shitalban Patel; Young Jeong; Harumi Takahashi; Larisa H Cavallari; Minoli A Perera
Journal:  Transl Res       Date:  2014-11-22       Impact factor: 7.012

9.  Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus).

Authors:  Erik Rytting; Xiaoming Wang; Daria I Vernikovskaya; Ying Zhan; Cassondra Bauer; Susan M Abdel-Rahman; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Drug Metab Dispos       Date:  2014-08-05       Impact factor: 3.922

10.  CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects.

Authors:  Larisa H Cavallari; David Vaynshteyn; Kimberly M Freeman; Danxin Wang; Minoli A Perera; Harumi Takahashi; Katrzyna Drozda; Shitalben R Patel; Hyunyoung Jeong
Journal:  Pharmacogenet Genomics       Date:  2013-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.